ArticlePloS one2014

Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.

Melissa Paoloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.